NASDAQ:ICCM IceCure Medical (ICCM) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ICCM Stock Alerts $1.19 +0.01 (+0.85%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$1.17▼$1.2250-Day Range$1.18▼$1.4852-Week Range$0.52▼$1.57Volume99,421 shsAverage Volume581,092 shsMarket Capitalization$54.29 millionP/E RatioN/ADividend YieldN/APrice Target$2.95 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get IceCure Medical alerts: Email Address IceCure Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside147.9% Upside$2.95 Price TargetShort InterestHealthy1.21% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.56Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.31) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.30 out of 5 starsMedical Sector513th out of 939 stocksSurgical & Medical Instruments Industry57th out of 96 stocks 3.5 Analyst's Opinion Consensus RatingIceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.95, IceCure Medical has a forecasted upside of 147.9% from its current price of $1.19.Amount of Analyst CoverageIceCure Medical has only been the subject of 2 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.21% of the float of IceCure Medical has been sold short.Short Interest Ratio / Days to CoverIceCure Medical has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IceCure Medical has recently decreased by 57.32%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldIceCure Medical does not currently pay a dividend.Dividend GrowthIceCure Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICCM. Previous Next 2.0 News and Social Media Coverage News SentimentIceCure Medical has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for IceCure Medical this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ICCM on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added IceCure Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IceCure Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.44% of the stock of IceCure Medical is held by insiders.Percentage Held by InstitutionsOnly 0.62% of the stock of IceCure Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for IceCure Medical are expected to grow in the coming year, from ($0.31) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IceCure Medical is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IceCure Medical is -3.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIceCure Medical has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. About IceCure Medical Stock (NASDAQ:ICCM)IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a single probe system for the treatment of breast tumors; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Read More ICCM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICCM Stock News HeadlinesMarch 27, 2024 | prnewswire.comIceCure Medical to Report 2023 Full Year Financial & Operational Results on April 3, 2024March 21, 2024 | americanbankingnews.comHC Wainwright Reaffirms "Buy" Rating for IceCure Medical (NASDAQ:ICCM)March 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 21, 2024 | americanbankingnews.comIceCure Medical (NASDAQ:ICCM) Price Target Raised to $2.90March 19, 2024 | markets.businessinsider.comIceCure Medical: ICE3 Cryoablation Breast Cancer Study Shows Positive ResultsMarch 19, 2024 | finance.yahoo.comIceCure Medical Reports Positive Topline Results From ICE3 Cryoablation Breast Cancer Study: Achievement of 96.39% Recurrence Free Rate Brings Company One Step Closer to Providing Women a Non-Surgical Alternative to LumpectomyMarch 12, 2024 | prnewswire.comIceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogen Flow Control to Optimize Patient OutcomesMarch 7, 2024 | prnewswire.comIceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services ConferenceMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…March 7, 2024 | prnewswire.comIceCure Medical to Present at 34th Annual Oppenheimer Healthcare MedTech & Services ConferenceMarch 5, 2024 | markets.businessinsider.comIceCure Medical: Strong Buy on Promising Clinical Results and Positive FDA DevelopmentsMarch 4, 2024 | prnewswire.comIceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024February 27, 2024 | prnewswire.comFourth BRIIT Conference in India Features IceCure's ProSense® in Breast Cancer Imaging & Interventions WorkshopFebruary 26, 2024 | prnewswire.comStudy Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast CancerFebruary 24, 2024 | msn.comIceCure Medical (ICCM) Price Target Increased by 5.85% to 3.14February 15, 2024 | finance.yahoo.comIceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in JapanFebruary 15, 2024 | prnewswire.comIceCure's ProSense® to be Featured at Two Upcoming Medical Conferences in JapanJanuary 30, 2024 | msn.comFDA agrees to review IceCure request for De Novo classificationJanuary 30, 2024 | finance.yahoo.comU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo Classification Request for Marketing Authorization of ProSense® for Early-Stage Breast CancerJanuary 29, 2024 | finance.yahoo.comIceCure Medical's Breast Cryoablation Gains Prominence in the U.S., as Society of Interventional Oncology Annual Meeting Features its First Breast Cryoablation Master ClassJanuary 16, 2024 | finance.yahoo.comIceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of CryoablationJanuary 13, 2024 | finanznachrichten.deIceCure Medical Ltd.: IceCure Medical Regains Compliance with Nasdaq Minimum Closing Bid Price RuleJanuary 10, 2024 | finance.yahoo.comIceCure Medical CEO Issues Letter to Shareholders & Reports Increase in Sales in Preliminary Unaudited 2023 ResultsJanuary 3, 2024 | markets.businessinsider.comIceCure Medical Publishes Mouse Study On ProSense That Boosts Immune Response Against CancerJanuary 3, 2024 | finance.yahoo.comNew Study Reports IceCure's ProSense® Boosts Immune Response Against Cancer: Enhances CD8+ T Cell ResponseDecember 13, 2023 | finance.yahoo.comStudy Using IceCure's ProSense® Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"November 29, 2023 | finance.yahoo.comIceCure's ProSense® Deepens Regulatory Approval in IndiaSee More Headlines Receive ICCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/22/2023Today3/28/2024Next Earnings (Estimated)4/03/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:ICCM CUSIPN/A CIK1584371 Webwww.icecure-medical.com Phone972-4623-0333Fax972-4623-0222Employees65Year FoundedN/APrice Target and Rating Average Stock Price Target$2.95 High Stock Price Target$3.00 Low Stock Price Target$2.90 Potential Upside/Downside+147.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,980,000.00 Net Margins-535.84% Pretax MarginN/A Return on Equity-77.41% Return on Assets-62.95% Debt Debt-to-Equity Ratio0.03 Current Ratio4.03 Quick Ratio3.41 Sales & Book Value Annual Sales$3.09 million Price / Sales17.57 Cash FlowN/A Price / Cash FlowN/A Book Value$0.56 per share Price / Book2.13Miscellaneous Outstanding Shares45,620,000Free Float44,510,000Market Cap$54.29 million OptionableNot Optionable Beta0.75 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Eyal Shamir (Age 63)CEO & Director Comp: $467.32kMr. Ronen Tsimerman CPA (Age 55)CFO & COO Comp: $331.8kMs. Tlalit Bussi Tel-Tzure (Age 53)Vice President of Business Development & Global Marketing Comp: $279.34kMs. Merav Nir Dotan (Age 55)Vice President of Human Resources Comp: $197.96kMs. Galit Malik (Age 51)Vice President of Operations & Service Key CompetitorsInspireMDNYSE:NSPRCarmellNASDAQ:CTCXCytosorbentsNASDAQ:CTSOPro-DexNASDAQ:PDEXBeyond AirNASDAQ:XAIRView All CompetitorsInstitutional OwnershipCitadel Advisors LLCSold 21,522 shares on 2/15/2024Ownership: 0.112%View All Institutional Transactions ICCM Stock Analysis - Frequently Asked Questions Should I buy or sell IceCure Medical stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares. View ICCM analyst ratings or view top-rated stocks. What is IceCure Medical's stock price target for 2024? 2 Wall Street analysts have issued 1 year price targets for IceCure Medical's stock. Their ICCM share price targets range from $2.90 to $3.00. On average, they expect the company's stock price to reach $2.95 in the next year. This suggests a possible upside of 147.9% from the stock's current price. View analysts price targets for ICCM or view top-rated stocks among Wall Street analysts. How have ICCM shares performed in 2024? IceCure Medical's stock was trading at $1.07 at the start of the year. Since then, ICCM shares have increased by 11.2% and is now trading at $1.19. View the best growth stocks for 2024 here. Are investors shorting IceCure Medical? IceCure Medical saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 242,700 shares, a decline of 57.3% from the February 29th total of 568,600 shares. Based on an average daily trading volume, of 550,100 shares, the short-interest ratio is currently 0.4 days. Currently, 1.2% of the company's shares are short sold. View IceCure Medical's Short Interest. When is IceCure Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 3rd 2024. View our ICCM earnings forecast. How were IceCure Medical's earnings last quarter? IceCure Medical Ltd (NASDAQ:ICCM) released its quarterly earnings results on Monday, May, 22nd. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.09) by $0.01. The firm had revenue of $0.71 million for the quarter, compared to the consensus estimate of $0.95 million. IceCure Medical had a negative net margin of 535.84% and a negative trailing twelve-month return on equity of 77.41%. During the same quarter in the previous year, the company posted ($0.12) earnings per share. What guidance has IceCure Medical issued on next quarter's earnings? IceCure Medical updated its FY 2023 earnings guidance on Wednesday, January, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.2 million-$3.2 million, compared to the consensus revenue estimate of $2.9 million. Who are IceCure Medical's major shareholders? IceCure Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Citadel Advisors LLC (0.11%). How do I buy shares of IceCure Medical? Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICCM) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IceCure Medical Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.